1. Home
  2. EYPT vs COHU Comparison

EYPT vs COHU Comparison

Compare EYPT & COHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • COHU
  • Stock Information
  • Founded
  • EYPT 1987
  • COHU 1947
  • Country
  • EYPT United States
  • COHU United States
  • Employees
  • EYPT N/A
  • COHU N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • COHU Electrical Products
  • Sector
  • EYPT Industrials
  • COHU Industrials
  • Exchange
  • EYPT Nasdaq
  • COHU Nasdaq
  • Market Cap
  • EYPT 967.4M
  • COHU 1.0B
  • IPO Year
  • EYPT 2005
  • COHU N/A
  • Fundamental
  • Price
  • EYPT $11.76
  • COHU $23.61
  • Analyst Decision
  • EYPT Strong Buy
  • COHU Buy
  • Analyst Count
  • EYPT 5
  • COHU 6
  • Target Price
  • EYPT $27.40
  • COHU $28.20
  • AVG Volume (30 Days)
  • EYPT 1.4M
  • COHU 846.9K
  • Earning Date
  • EYPT 11-05-2025
  • COHU 10-29-2025
  • Dividend Yield
  • EYPT N/A
  • COHU N/A
  • EPS Growth
  • EYPT N/A
  • COHU N/A
  • EPS
  • EYPT N/A
  • COHU N/A
  • Revenue
  • EYPT $51,898,000.00
  • COHU $393,941,000.00
  • Revenue This Year
  • EYPT N/A
  • COHU $13.76
  • Revenue Next Year
  • EYPT N/A
  • COHU $12.59
  • P/E Ratio
  • EYPT N/A
  • COHU N/A
  • Revenue Growth
  • EYPT 2.99
  • COHU N/A
  • 52 Week Low
  • EYPT $3.91
  • COHU $12.57
  • 52 Week High
  • EYPT $14.91
  • COHU $29.42
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 42.93
  • COHU 60.81
  • Support Level
  • EYPT $11.15
  • COHU $21.23
  • Resistance Level
  • EYPT $12.47
  • COHU $22.98
  • Average True Range (ATR)
  • EYPT 0.68
  • COHU 0.96
  • MACD
  • EYPT -0.08
  • COHU 0.20
  • Stochastic Oscillator
  • EYPT 23.37
  • COHU 68.06

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

Share on Social Networks: